Investigational Drug Service, Duke University Hospital — Durham, North Carolina

Investigational Drug Service, Duke University Hospital is a clinical research site located in Durham, North Carolina, United States 27710.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Investigational Drug Service, Duke University Hospital has participated in 2 clinical trials.

Therapeutic areas: Sickle Cell Disease, Venous Thromboembolism.

Sponsors: Pfizer, Bristol-Myers Squibb.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigational Drug Service, Duke University Hospital?

Investigational Drug Service, Duke University Hospital has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigational Drug Service, Duke University Hospital conducted?

Investigational Drug Service, Duke University Hospital has 2 clinical trials on record. Their work covers Sickle Cell Disease, Venous Thromboembolism.

Is Investigational Drug Service, Duke University Hospital accredited by Crixeo Health?

Investigational Drug Service, Duke University Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigational Drug Service, Duke University Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.